View of 946 – Predictors of four versus six cycles of adjuvant docetaxel–cyclophosphamide in hormone receptor-positive early breast cancer

Return to Article Details 946 – Predictors of four versus six cycles of adjuvant docetaxel–cyclophosphamide in hormone receptor-positive early breast cancer Download Download PDF